51
Participants
Start Date
March 31, 2012
Primary Completion Date
December 31, 2012
Study Completion Date
December 31, 2012
Ketotifen
After meeting the full eligibility requirement, participants will be randomized. From week 1 to 2, subjects will receive either ketotifen 1 mg by mouth, twice a day or the equivalent placebo. Thereafter, subjects will take ketotifen to 2 mg by mouth twice a day or the equivalent placebo.
Placebo (Sugar Pill)
After meeting the full eligibility requirement, participants will be randomized. From week 1 to 2, subjects will receive either ketotifen 1 mg BID or the equivalent placebo. Thereafter, subjects will take ketotifen to 2 mg BID or the equivalent placebo.
IU Clincial Research Center for Pain and Fibromyalgia, Indianapolis
Indiana University
OTHER